Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Cryo-Cell International, Inc. - Common Stock (NY:CCEL)

3.250 +0.280 (+9.43%)

Official Closing Price Updated: 4:10 PM EDT, Mar 26, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	19,842
Open	2.930
Bid (Size)	2.730 (200)
Ask (Size)	3.370 (500)
Prev. Close	2.970
Today's Range	2.930 - 3.250
52wk Range	2.720 - 6.650
Shares Outstanding	8,288,414
Dividend Yield	9.23%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Cryo-Cell Receives NYSE American Continued Listing Notice

March 12, 2026

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025

February 27, 2026

From Cryo-Cell International, Inc.

Via Business Wire

Performance

YTD	-5.2%	-5.2%
1 Month	-4.4%	-4.4%
3 Month	-5.8%	-5.8%
6 Month	-33.9%	-33.9%
1 Year	-49.1%	-49.1%

More News

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results

October 15, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell International, Inc. Provides Dividend Update

August 14, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Looking Into Cryo-Cell International's Return On Capital Employed ↗

April 24, 2023

Via Benzinga

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results

July 15, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend

May 08, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results

April 15, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024

February 28, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives

January 29, 2025

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend

October 30, 2024

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results

October 15, 2024

From Cryo-Cell International, Inc.

Via Business Wire

CCEL Stock Earnings: Cryo-Cell International Beats EPS, Beats Revenue for Q2 2024 ↗

July 15, 2024

Via InvestorPlace

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results

July 15, 2024

From Cryo-Cell International, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 26, 2024

Via Benzinga

CCEL Stock Earnings: Cryo-Cell International Beats EPS, Misses Revenue for Q1 2024 ↗

April 15, 2024

Via InvestorPlace

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results

April 15, 2024

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

March 25, 2024

From Cryo-Cell International, Inc.

Via Business Wire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

February 28, 2024

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results

October 12, 2023

From Cryo-Cell International, Inc.

Via Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results

July 14, 2023

From Cryo-Cell International, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 26, 2023

Via Benzinga

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results

April 21, 2023

From Cryo-Cell International, Inc.

Via Business Wire

Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday ↗

October 05, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 04, 2022

Via Benzinga

Frequently Asked Questions

Is Cryo-Cell International, Inc. - Common Stock publicly traded?

Yes, Cryo-Cell International, Inc. - Common Stock is publicly traded.

What exchange does Cryo-Cell International, Inc. - Common Stock trade on?

Cryo-Cell International, Inc. - Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Cryo-Cell International, Inc. - Common Stock?

The ticker symbol for Cryo-Cell International, Inc. - Common Stock is CCEL on the New York Stock Exchange

What is the current price of Cryo-Cell International, Inc. - Common Stock?

The current price of Cryo-Cell International, Inc. - Common Stock is 3.250

When was Cryo-Cell International, Inc. - Common Stock last traded?

The last trade of Cryo-Cell International, Inc. - Common Stock was at 03/26/26 04:10 PM ET

What is the market capitalization of Cryo-Cell International, Inc. - Common Stock?

The market capitalization of Cryo-Cell International, Inc. - Common Stock is 26.94M

How many shares of Cryo-Cell International, Inc. - Common Stock are outstanding?

Cryo-Cell International, Inc. - Common Stock has 27M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.